4//SEC Filing
Hughes Steven George 4
Accession 0001599901-25-000159
CIK 0001599901other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:07 PM ET
Size
8.7 KB
Accession
0001599901-25-000159
Insider Transaction Report
Form 4
Hughes Steven George
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-08-13$6.57/sh+1,542$10,131→ 40,409 total - Sale
Common Stock
2025-08-13$46.66/sh−1,542$71,950→ 38,867 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-08-13−1,542→ 50,875 totalExercise: $6.57Exp: 2033-09-10→ Common Stock (1,542 underlying)
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.
- [F2]This option was granted on September 11, 2023 and vests in equal installments of 1,542 shares on each monthly anniversary of such grant date, until it is fully vested and exercisable on September 11, 2027.
Documents
Issuer
Avidity Biosciences, Inc.
CIK 0001599901
Entity typeother
Related Parties
1- filerCIK 0001747528
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:07 PM ET
- Size
- 8.7 KB